Skip to main content
. 2019 Jul 3;188(10):1794–1800. doi: 10.1093/aje/kwz157

Figure 1.

Figure 1.

Percentages of diabetic Israelis at risk of cancer who were using metformin (solid curve) and other glucose-lowering medications (dotted curve), by years since diabetes diagnosis, 2002–2012. For calculation of trajectories, see Table 2 (third plus fourth columns divided by second column for metformin trajectory; sixth plus seventh columns divided by second column for other glucose-lowering medication trajectory).